The Worldwide Market for Cancer Diagnostics, 3rd Edition

Abstract

Who are the major players in testing for the number two killer in the world? What revenues can companies competing in this market expect in the next five years? How will the impact of trends such as an increased role of pharmacodiagnostics, the use of multiplex assays and a new emphasis on service products influence cancer diagnostics? These questions and more are answered in Kalorama Information' s Worldwide Market for Cancer Diagnostics, 3rd Edition. Diagnostic tests for effective cancer screening are obviously needed more than ever. As cancer becomes more treatable, diagnostics are finding multiple expanded roles, including pharmacodiagnostics for matching the targeted treatment to the patient and ongoing disease monitoring as treatable cancer enters the realm of the chronic disease. Kalorama Information' s Worldwide Market for Cancer Diagnostics, 3rd Edition represents the third time Kalorama has engaged in an exhaustive study on the status of this important diagnostic market.

This report includes detailed market analysis of the following screening tests:

• DR-70
• HAAH
• ECPKA
• The Cancer Profile

As well as these specific cancer-screening tests:

• Bladder Cancer
• Breast Cancer
• Cervical Cancer
• Colon Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer

This latest edition of Kalorama' s study takes a fresh look at all of these developments both qualitatively and quanititatively. The report provides revenue and growth forecasts through 2012 and, as in the previous edition, analyzes the market in two ways:

• Tests for specific cancers, and
• Cancer tests in specific IVD segments

This allows the reader to match his or her own situation to the market at large.

In addition to extensive reviews of products on the market and in development in each segment, the report also provides the most extensive review of innovative companies yet compiled in this market with profiles of over 150 companies active in the segment.

Kalorama' s diagnostics industry analyst Shara Rosen provides the rigorous analysis and thoughtful research that has been made her market reports the backbone of diagnostic market decision-making for years.